Gent, Belgium · Founded 2020 · Privately Held (backing)
Developer of monoclonal antibodies designed to bring to the market cost-effective services that ultimately benefit animals, producers, and consumers. Animab is based in Gent, Belgium and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $25.4 million.
Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$25.4M
Last round
—
Team — not yet on record
No current team members for Animab are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Animab with a free account
·Watch Animab: the Monday email on marks, rounds and moves
